Abstract

To evaluate the clinical outcomes after fenestrated endovascular aortic aneurysm repair (F-EVAR) in octogenarians. Between 2002 and 2012, all data from patients treated with custom-made fenestrated endografts for elective juxtarenal or pararenal aortic aneurysms in 2 high-volume centers (Malmö, Sweden & Lille, France) were prospectively entered in a computer database. Demographics and perioperative and follow-up results of patients aged ≥80 years (group 1) and patients aged <80 (group 2) were compared. A total of 288 patients (33 in group 1 and 255 in group 2) were treated with fenestrated endografts during the study period. Except for median age, tobacco use, and maximal transaortic diameter (P = 0.001), both groups were comparable. The number of fenestrations, procedure duration, contrast media volume, length of stay, and number of secondary interventions were comparable. The 30-day mortality rate was higher in the octogenarian group (9% vs. 1.6%, P = 0.041). Median follow-up was 25 months. Two-year survival rate according to Kaplan-Meier method was 77.8% in group 1 (95% confidence interval, 61.8-93.9) and 89.0% in group 2 (P = 0.121). Overall mortality during the follow-up period was significantly higher in octogenarians (P < 0.006). F-EVAR in octogenarians is associated with a higher 30-day mortality rate but has similar midterm outcomes compared with younger patients and should be considered as an acceptable therapeutic option in patients with satisfactory life expectancy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.